Memorial Sloan-Kettering Cancer Center
Also known as: Memorial Hospital for Cancer and Allied Diseases | Memorial Sloan Kettering Cancer | Memorial Sloan Kettering Cancer Center | Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA | Memorial Sloan Kettering Cancer Center (MSKCC) | Memorial Sloan Kettering Cancer Centre, New York City, United States | Memorial Sloan Kettering Kids | Memorial Sloan Kettering, USA | MEM SLOAN-KETTERING | MSKCC
Highest phase reached
Phase 4
Timeline
1880s
- Jul 1, 1884
Memorial Sloan-Kettering Cancer Center— Founded
2010s
- Dec 8, 2016
fludeoxyglucose f-18— Marketing Organization
Drugs by trial phase (371 distinct, 424 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Phase 2 (228 own, 0 via acquisition)
Phase 1 (84 own, 0 via acquisition)
Other trials (15 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenocarcinoma, Follicular
- Adenoma, Islet Cell
- Adenoma, Oxyphilic
- Adenomyoepithelioma
- Alzheimer Disease
- Amyloidosis
- Anemia
- Anemia, Aplastic
- Astrocytoma
- Basal Cell Carcinoma
- Brain Neoplasms
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinosarcoma
- Cholangiocarcinoma
- Chondrosarcoma
- Colorectal Neoplasms
- Communicable Diseases
- Cytomegalovirus Infections
- Desmoplastic Small Round Cell Tumor
- Diarrhea
- Disease
- Endometrial Neoplasms
- Ependymoma
- Esophageal Neoplasms
- Fanconi Anemia
- Fanconi Syndrome
- Glioblastoma
- Glioma
- Graft vs Host Disease
- Head and Neck Neoplasms
- Hematologic Diseases
- Hematologic Neoplasms
- Hemoglobinopathies
- Histiocytoma, Malignant Fibrous
- Hodgkin Disease
- Hypersensitivity
- Immunoglobulin Light-chain Amyloidosis
- Infections
- Kidney Neoplasms
- Leiomyosarcoma
- Leukemia
- Leukemia, Hairy Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liposarcoma
- Liver Diseases
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphomatoid Papulosis
- Lymphopenia
- Medulloblastoma
- Melanoma
- Meningeal Carcinomatosis
- Mesothelioma
- Metabolic Diseases
- Mixed Tumor, Mullerian
- Multiple Myeloma
- Mycoses
- Mycosis Fungoides
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasm, Residual
- Neoplasms
- Neoplasms, Basal Cell
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Neoplasms, Squamous Cell
- Neurilemmoma
- Neuroblastoma
- Neuroendocrine Tumors
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Neurofibromatosis 2
- Neuroma, Acoustic
- Osteosarcoma
- Ovarian Neoplasms
Marketed drugs (1)
Recent trials (50)
- NCT04501757Overall official - principal investigatorN/A—
- NCT05064306Lead sponsorN/A—
- NCT04571229Overall official - principal investigatorN/A—
- NCT05064306Overall official - principal investigatorN/A—
- NCT04501757Lead sponsorN/A—
- NCT04571229Lead sponsorN/A—
- NCT07303894Lead sponsorPhase 2Jan 31, 2026
- NCT07303894OfficialPhase 2Jan 31, 2026
- NCT07265674OfficialPhase 3Dec 31, 2025
- NCT07231952Lead sponsorPhase 2Nov 11, 2025
- NCT07089992Lead sponsorPhase 2Nov 11, 2025
- NCT07089992OfficialPhase 2Nov 11, 2025
- NCT07231952OfficialPhase 2Nov 11, 2025
- NCT07227636OfficialPhase 2Nov 7, 2025
- NCT07227636Lead sponsorPhase 2Nov 7, 2025
Details
- Founded
- New York, NY, US Jul 1, 1884
- Last known activity
- Jan 31, 2026
Notes
Removed from links with Cornell University as it is an independent entity